![Pharmaceutics | Free Full-Text | Therapeutic Approaches to Treat Mitochondrial Diseases: “One-Size-Fits-All” and “Precision Medicine” Strategies Pharmaceutics | Free Full-Text | Therapeutic Approaches to Treat Mitochondrial Diseases: “One-Size-Fits-All” and “Precision Medicine” Strategies](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-01083/article_deploy/html/images/pharmaceutics-12-01083-g001.png)
Pharmaceutics | Free Full-Text | Therapeutic Approaches to Treat Mitochondrial Diseases: “One-Size-Fits-All” and “Precision Medicine” Strategies
![An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological Toxicity: Molecular Therapy An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological Toxicity: Molecular Therapy](https://www.cell.com/cms/attachment/e6bd5e04-ea61-4c42-bac0-baa5606dabce/gr1_lrg.jpg)
An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological Toxicity: Molecular Therapy
![Espanyol | Diego López on Madrid reunion: “We're ready to compete” Diego López on Madrid reunion: “We're ready to compete” - AS USA Espanyol | Diego López on Madrid reunion: “We're ready to compete” Diego López on Madrid reunion: “We're ready to compete” - AS USA](https://img.asmedia.epimg.net/resizer/9JNOJyYn2vRT6nQ6JrFsKOiLeVA=/1952x1098/cloudfront-eu-central-1.images.arcpublishing.com/diarioas/WKAWILFJ7ZJ7JB2Q3VZ4HRXYOQ.jpg)